(Q37187630)

18 August 2017

How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design--a reanalysis of 4 trials (English)

1 reference

18 August 2017

F M-S Barthel

1

1 reference

18 August 2017

M K B Parmar

series ordinal

2

1 reference

18 August 2017

P Royston

series ordinal

3

1 reference

18 August 2017

17 April 2009

1 reference

18 August 2017

1 reference

18 August 2017

10

1 reference

18 August 2017

21

1 reference

https://scigraph.springernature.com/pub.10.1186/1745-6215-10-21

18 August 2017

0 references

cites work

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680399

Interim futility analysis with intermediate endpoints

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680399

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680399

Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680399

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680399

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19374739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1745-6215-10-21

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19374739

1 reference